GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Hepatocellular Carcinoma · Liver Cancer, Adult · Liver Neoplasm · Metastatic Liver Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • City of Hope, Duarte, California, United States

    Contact: Study coordinator (Kimberley Le, RN, MSN) · kimle@coh.org · 626-218-2997
    Contact: Principal Investigator (Daneng Li, MD)
  • Kansas University Medical Center, Principal Investigator:, Westwood, Kansas, United States

  • Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States

  • Montefiore Einstein Comprehensive Cancer Center, The Bronx, New York, United States

    Contact: Study coordinator (Molly McHugh) · momchugh@montefiore.org · 718-920-7426
    Contact: Principal Investigator (R. Alejandro Sica, MD)
  • Oregon Health and Sciences University, Portland, Oregon, United States

    Contact: Study coordinator (Fatema Fareh) · farehf@ohsu.edu · 503-418-0345
    Contact: Principal Investigator (Richard Maziarz, MD)
    Adel Kardosh, MD (Sub-investigator)
  • University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas, United States

    Contact: Study coordinator (Amala Poulose) · Amala.Poulose@UTSouthwestern.edu
    Contact: Principal Investigator (David Hsieh, MD)
    Farrukh Awan, MD (Sub-investigator)
  • Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington, United States

    Contact: Study coordinator (Shelby Colden) · scolden2@fredhutch.org · 206-667-5134
    Contact: Principal Investigator (William Harris, MD)
  • National Taiwan University Cancer Center, Taipei, Taiwan

    Contact: Study coordinator (Guanlieng Chen) · guanlieng.chen@doint.com.tw
    Contact: Principal Investigator (Chiun Hsu, MD, PhD)
מובילי המחקר
  • Pei Wang, PhD

    Study Director

    Eureka Therapeutics Inc.